![]() For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.Ībbott - A Leader in Rapid Point-of-Care Diagnostics. Check with your local representative for availability in specific markets. Not all products are available in all regions. GDPR Statement | Declaration for California Compliance Law. ![]() Any person depicted in such photographs is a model. Photos displayed are for illustrative purposes only. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. If it turns out that you do have COVID-19, our providers will set you up with a treatment plan that could include medication, plenty of fluids, rest, and of course, staying home. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. This website is governed by applicable U.S. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. Disregard dates printed on components.” Original printed expiration date may be covered by this new label. ^Some kits may have an additional label added that states “New expiry date. **Abbott conducted a computational analysis of the detection of multiple SARS-COV-2 strains, including the OMICRON variant, and predicts no impact in the performance of our BinaxNOW COVID-19 Antigen Self Test. *1H 2023 Nielsen Test Sales Market Data on file § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. It has been authorized by the FDA under an emergency use authorization. The BinaxNOW™ COVID-19 Antigen Self Test has not been FDA cleared or approved.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |